AU2001251665A1 - Medicine response assay in respiratory disease - Google Patents
Medicine response assay in respiratory diseaseInfo
- Publication number
- AU2001251665A1 AU2001251665A1 AU2001251665A AU5166501A AU2001251665A1 AU 2001251665 A1 AU2001251665 A1 AU 2001251665A1 AU 2001251665 A AU2001251665 A AU 2001251665A AU 5166501 A AU5166501 A AU 5166501A AU 2001251665 A1 AU2001251665 A1 AU 2001251665A1
- Authority
- AU
- Australia
- Prior art keywords
- respiratory disease
- response assay
- medicine response
- medicine
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003556 assay Methods 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19791300P | 2000-04-17 | 2000-04-17 | |
| US60/197,913 | 2000-04-17 | ||
| US23660800P | 2000-09-29 | 2000-09-29 | |
| US60/236,608 | 2000-09-29 | ||
| PCT/US2001/012534 WO2001079560A2 (en) | 2000-04-17 | 2001-04-17 | Medicine response assay in respiratory disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001251665A1 true AU2001251665A1 (en) | 2001-10-30 |
Family
ID=26893274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001251665A Abandoned AU2001251665A1 (en) | 2000-04-17 | 2001-04-17 | Medicine response assay in respiratory disease |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6939674B2 (en) |
| EP (1) | EP1276906A2 (en) |
| JP (1) | JP2003530844A (en) |
| AU (1) | AU2001251665A1 (en) |
| CA (1) | CA2406090A1 (en) |
| WO (1) | WO2001079560A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4365099B2 (en) | 2001-04-20 | 2009-11-18 | ノボザイムス アクティーゼルスカブ | Lipoxygenase |
| US6897025B2 (en) * | 2002-01-07 | 2005-05-24 | Perlegen Sciences, Inc. | Genetic analysis systems and methods |
| WO2006010103A1 (en) * | 2004-07-07 | 2006-01-26 | Wisconsin Alumni Research Foundation | Genetic predictor of efficacy of anti-asthmatic agents for improving pulmonary function |
| US7811765B2 (en) * | 2006-10-12 | 2010-10-12 | Children's Hospital & Research Center At Oakland | Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease |
| JP2010527246A (en) * | 2007-05-18 | 2010-08-12 | バイオリポックス エービー | Method |
| EP4008327A1 (en) | 2009-04-29 | 2022-06-08 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| US20150005382A1 (en) * | 2011-10-04 | 2015-01-01 | Wake Forest University Health Sciences (WFUHS) | Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0896633A2 (en) * | 1996-05-06 | 1999-02-17 | Brigham And Women's Hospital | 5-lipoxygenase gene polymorphisms and their use in classifying patients |
| GB9717766D0 (en) * | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Methods |
| US6334099B1 (en) * | 1999-05-25 | 2001-12-25 | Digital Gene Technologies, Inc. | Methods for normalization of experimental data |
-
2001
- 2001-04-17 AU AU2001251665A patent/AU2001251665A1/en not_active Abandoned
- 2001-04-17 US US10/240,305 patent/US6939674B2/en not_active Expired - Fee Related
- 2001-04-17 WO PCT/US2001/012534 patent/WO2001079560A2/en not_active Ceased
- 2001-04-17 CA CA002406090A patent/CA2406090A1/en not_active Abandoned
- 2001-04-17 JP JP2001576944A patent/JP2003530844A/en active Pending
- 2001-04-17 EP EP01925068A patent/EP1276906A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001079560A3 (en) | 2002-10-17 |
| US6939674B2 (en) | 2005-09-06 |
| EP1276906A2 (en) | 2003-01-22 |
| CA2406090A1 (en) | 2001-10-25 |
| JP2003530844A (en) | 2003-10-21 |
| WO2001079560A2 (en) | 2001-10-25 |
| US20030162193A1 (en) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001244188A1 (en) | Medicaments against viral diseases | |
| AU2001269529A1 (en) | Medicine comprising dicyanopyridine derivative | |
| AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
| AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
| AU2001269508A1 (en) | Drugs or cosmetics | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| AU2002221099A1 (en) | Combination drugs | |
| AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
| AU2001251665A1 (en) | Medicine response assay in respiratory disease | |
| AU2001232244A1 (en) | Drug comprising combination | |
| AU2001270129A1 (en) | Human phosphodiesterases | |
| AU2001261552A1 (en) | Disposable respirator | |
| IL151019A0 (en) | Microcompetition and human disease | |
| AU2001282527A1 (en) | Antiparkinsonism drugs | |
| AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
| AU2001228784A1 (en) | Inositol derivatives and their pharmaceutical use | |
| AU2001286575A1 (en) | 15985, a human serine/threonine protein kinase family member and uses thereof | |
| AU2001297710A1 (en) | Integrated drug development techniques | |
| AU2001258569A1 (en) | Alzheimer's disease assay | |
| AU2001295337A1 (en) | E. histolytica-specific antibodies and clinical uses thereof | |
| AU2001278130A1 (en) | 57250, a human sugar transporter family member and uses thereof | |
| AU2001219899A1 (en) | Medicine ball | |
| GB9907234D0 (en) | Drug assay | |
| AU2001272552A1 (en) | Oxygen-enriched agent and the use thereof for therapeutic purposes | |
| AU2001290565A1 (en) | Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |